Literature DB >> 32459339

Incidence of HCV Reinfection Among HIV-Positive MSM and Its Association With Sexual Risk Behavior: A Longitudinal Analysis.

Astrid M Newsum1,2, Amy Matser1, Janke Schinkel3, Marc van der Valk2, Kees Brinkman4, Arne van Eeden5, Fanny N Lauw6, Bart J A Rijnders7, Thijs J W van de Laar8,9, Marita van de Kerkhof1,2, Colette Smit10, Anders Boyd1,10, Joop E Arends11, Maria Prins1,2.   

Abstract

BACKGROUND: Human immunodeficiency virus (HIV)-positive men who have sex with men (MSM) are at high risk of hepatitis C virus (HCV) reinfection following clearance of HCV, but risk factors specifically for reinfection have never been comprehensively assessed.
METHODS: Using data from a prospective observational cohort study among HIV-positive MSM with an acute HCV infection (MOSAIC), the incidence of HCV reinfection following spontaneous clearance or successful treatment was assessed. A univariable Bayesian exponential survival model was used to identify risk factors associated with HCV reinfection.
RESULTS: In total, 122 HIV-positive MSM who had a spontaneously cleared or successfully treated HCV infection between 2003 and 2017 were included. During a median follow-up of 1.4 years (interquartile range [IQR] 0.5-3.8), 34 HCV reinfections were observed in 28 patients. The incidence of HCV reinfection was 11.5/100 person-years and among those with reinfection, median time to reinfection was 1.3 years (IQR 0.6-2.7). HCV reinfection was associated with receptive condomless anal intercourse, sharing of sex toys, group sex, anal rinsing before sex, ≥10 casual sex partners in the last 6 months, nadir CD4 cell count <200 cells/mm3, and recent CD4 cell count <500 cells/mm3.
CONCLUSIONS: Incidence of HCV reinfection was high and strongly associated with sexual risk behavior, highlighting the need for interventions to reduce risk behavior and prevent HCV reinfections among HIV-positive MSM.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HCV reinfection incidence; MSM; acute hepatitis C virus infection; risk factors

Mesh:

Year:  2021        PMID: 32459339     DOI: 10.1093/cid/ciaa645

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  8 in total

1.  Performance of Hepatitis C Virus (HCV) Core Antigen Assay in the Diagnosis of Recently Acquired HCV Infection among High-Risk Populations.

Authors:  Hsin-Yun Sun; Wang-Da Liu; Chih-Wen Wang; Yu-Ju Wei; Kuan-Yin Lin; Yu-Shan Huang; Li-Hsin Su; Yi-Ting Chen; Wen-Chun Liu; Yi-Chin Su; Yea-Wen Chen; Yu-Chung Chuang; Po-Liang Lu; Chien-Ching Hung; Ming-Lung Yu
Journal:  Microbiol Spectr       Date:  2022-05-17

2.  Hepatitis C elimination in people living with HIV - the importance of biomedical and behavioural interventions.

Authors:  Daniela K van Santen; Rachel Sacks-Davis; Margaret Hellard
Journal:  J Int AIDS Soc       Date:  2020-07       Impact factor: 5.396

3.  Screening for Sexually Transmitted Infections During Hepatitis C Treatment to Predict Reinfection Among People With HIV.

Authors:  Lucas A Hill; Natasha K Martin; Francesca J Torriani; Sonia Jain; Huifang Qin; Wm Christopher Mathews; Edward R Cachay
Journal:  Open Forum Infect Dis       Date:  2020-12-30       Impact factor: 3.835

4.  Usability, acceptability, and self-reported impact of an innovative hepatitis C risk reduction intervention for men have sex with men: A mixed methods study.

Authors:  Tamara Prinsenberg; Joël Illidge; Paul Zantkuijl; Maarten Bedert; Maria Prins; Marc van der Valk; Udi Davidovich
Journal:  PLoS One       Date:  2022-02-18       Impact factor: 3.240

5.  Continued Low Rates of Hepatitis C Virus (HCV) Recurrence in HCV/HIV- and HCV-Infected Participants Who Achieved Sustained Virologic Response After Direct-Acting Antiviral Treatment: Final Results From the AIDS Clinical Trials Group A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS).

Authors:  David L Wyles; Minhee Kang; Roy M Matining; Robert L Murphy; Marion G Peters
Journal:  Open Forum Infect Dis       Date:  2021-10-14       Impact factor: 4.423

6.  Reinfection rate of hepatitis C in HIV-1 positive men who have sex with men: A systematic review and meta-analysis.

Authors:  Zhengwei Wan; Ping Sun; Emmanuel Enoch Dzakah; Liping Huang; Ping Shuai; Yuping Liu
Journal:  Front Public Health       Date:  2022-07-29

7.  Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study.

Authors:  Chen-Hua Liu; Hsin-Yun Sun; Cheng-Yuan Peng; Szu-Min Hsieh; Sheng-Shun Yang; Wei-Yu Kao; Yu-Lueng Shih; Chih-Lin Lin; Chun-Jen Liu; Wang-Hui Sheng; Yi-Chun Lo; Wen-Chun Liu; Jo-Hsuan Wu; Tung-Hung Su; Tai-Chung Tseng; Pei-Jer Chen; Chien-Ching Hung; Jia-Horng Kao
Journal:  Open Forum Infect Dis       Date:  2022-07-22       Impact factor: 4.423

8.  The 'Viennese epidemic' of acute HCV in the era of direct-acting antivirals.

Authors:  David Chromy; David J M Bauer; Benedikt Simbrunner; Matthias Jachs; Lukas Hartl; Philipp Schwabl; Caroline Schwarz; Armin Rieger; Katharina Grabmeier-Pfistershammer; Michael Trauner; Peter Ferenci; Mattias Mandorfer; Michael Gschwantler; Thomas Reiberger
Journal:  J Viral Hepat       Date:  2022-03-15       Impact factor: 3.517

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.